Juno Therapeutics IPO Research Information

Juno Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Juno Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Juno Therapeutics	JUNO - NASDAQ	$15.00-$18.00	$24.00	$39.00	11.02 million	12/19/2014
Underwriter(s): Morgan Stanley, J.P. Morgan, Goldman Sachs & Co.
Co-Manager(s): Leerink Partners
Industry: Health Care
Filing(s): Filed 2014-01-01 Terms Added 2014-12-09 Amended Terms 2014-12-16

Juno Therapeutics Quote & Chart - Click for current quote - JUNO

About Juno Therapeutics (adapted from Juno Therapeutics prospectus):
They are building a fully-integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "JUNO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.